Objectives Our objectives were to estimate the public health outcomes of vaccinating Belgian children using an intranasal tetravalent live-attenuated influenza vaccine (QLAIV) combined with current coverage of high-risk/elderly individuals using the trivalent inactivated vaccine. Methods We used a deterministic, age-structured, dynamic model to simulate seasonal influenza transmission in the Belgian population under the current coverage or after extending vaccination with QLAIV to healthy children aged 2-17 years. Differential equations describe demographic changes, exposure to infectious individuals, infection recovery, and immunity dynamics. The basic reproduction number (R-0) was calibrated to the observed number of influenza doctor visits/year. Vaccine efficacy was 80 % (live-attenuated) and 59-68 % (inactivated). The 10-year incidence of symptomatic influenza was calculated with different coverage scenarios (add-on to current coverage). Results Model calibration yielded R-0 = 1.1. QLAIV coverage of 75 % of those aged 2-17 years averted 374,000 symptomatic cases/year (57 % of the current number), 244,000 of which were among adults (indirect effect). Vaccinating 75 % of those aged 2-11 years and 50 % of those aged 12-17 years averted 333,200 cases/year (213,000 adult cases/year). Vaccinating only healthy children aged 2-5 years generated direct protection but limited indirect protection, even with 90 % coverage (40,800 averted adult cases/year; -8.4 %). Targeting all children averted twice as many high-risk cases as targeting high-risk children only (8485 vs. 4965/year with 75 % coverage). Sensitivity analyses showed the robustness of results. Conclusions The model highlights the direct and indirect protection benefits when vaccinating healthy children with QLAIV in Belgium. Policies targeting only high-risk individuals or the youngest provide limited herd protection, as school-age children are important influenza vectors in the community.
机构:
QuintilesIMS Real World Evidence Solut, Davos Bldg,Da Vincilaan 7, B-1935 Zaventem, BelgiumQuintilesIMS Real World Evidence Solut, Davos Bldg,Da Vincilaan 7, B-1935 Zaventem, Belgium
Gerlier, L.
Lamotte, M.
论文数: 0引用数: 0
h-index: 0
机构:
QuintilesIMS Real World Evidence Solut, Davos Bldg,Da Vincilaan 7, B-1935 Zaventem, BelgiumQuintilesIMS Real World Evidence Solut, Davos Bldg,Da Vincilaan 7, B-1935 Zaventem, Belgium
Lamotte, M.
Greneche, S.
论文数: 0引用数: 0
h-index: 0
机构:
AstraZeneca, Rueil Malmaison, FranceQuintilesIMS Real World Evidence Solut, Davos Bldg,Da Vincilaan 7, B-1935 Zaventem, Belgium
Greneche, S.
Lenne, X.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Lille Nord France, Dept Med Informat, Lille, FranceQuintilesIMS Real World Evidence Solut, Davos Bldg,Da Vincilaan 7, B-1935 Zaventem, Belgium
Lenne, X.
Carrat, F.
论文数: 0引用数: 0
h-index: 0
机构:
UPMC Univ Paris 06, INSERM, Sorbonne Univ, IPLESP,UMRS 1136, Paris, France
St Antoine Hosp, AP HP, Dept Publ Hlth, Paris, FranceQuintilesIMS Real World Evidence Solut, Davos Bldg,Da Vincilaan 7, B-1935 Zaventem, Belgium
Carrat, F.
Weil-Olivier, C.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Paris VII, Dept Pediat, Paris, FranceQuintilesIMS Real World Evidence Solut, Davos Bldg,Da Vincilaan 7, B-1935 Zaventem, Belgium
Weil-Olivier, C.
Damm, O.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Bielefeld, Bielefeld Sch Publ Hlth, Dept Hlth Econ & Hlth Care Management, Bielefeld, GermanyQuintilesIMS Real World Evidence Solut, Davos Bldg,Da Vincilaan 7, B-1935 Zaventem, Belgium
Damm, O.
Schwehm, M.
论文数: 0引用数: 0
h-index: 0
机构:
ExploSYS GmbH, Leinfelden Echterdingen, GermanyQuintilesIMS Real World Evidence Solut, Davos Bldg,Da Vincilaan 7, B-1935 Zaventem, Belgium
机构:
Univ Hong Kong, Li Ka Shing Fac Med, Sch Clin Med, Dept Clin Oncol, Hong Kong, Peoples R ChinaUniv Hong Kong, Li Ka Shing Fac Med, Sch Clin Med, Dept Clin Oncol, Hong Kong, Peoples R China
Chan, Kenneth Sik-Kwan
Wong, Charlene Hoi-Lam
论文数: 0引用数: 0
h-index: 0
机构:
Univ Hong Kong, Li Ka Shing Fac Med, Sch Clin Med, Dept Clin Oncol, Hong Kong, Peoples R ChinaUniv Hong Kong, Li Ka Shing Fac Med, Sch Clin Med, Dept Clin Oncol, Hong Kong, Peoples R China
Wong, Charlene Hoi-Lam
Choi, Horace Cheuk-Wai
论文数: 0引用数: 0
h-index: 0
机构:
Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Peoples R China
Lab Data Discovery Hlth Ltd D24H, Hong Kong Sci Pk, Hong Kong, Peoples R ChinaUniv Hong Kong, Li Ka Shing Fac Med, Sch Clin Med, Dept Clin Oncol, Hong Kong, Peoples R China
机构:
Avir Green Hills Biotechnol, A-1180 Vienna, Austria
Univ Vienna, Inst Microbiol & Genet, A-1030 Vienna, AustriaAvir Green Hills Biotechnol, A-1180 Vienna, Austria
Wressnigg, Nina
Voss, Daniel
论文数: 0引用数: 0
h-index: 0
机构:
Robert Koch Inst, D-13353 Berlin, GermanyAvir Green Hills Biotechnol, A-1180 Vienna, Austria
Voss, Daniel
Wolff, Thorsten
论文数: 0引用数: 0
h-index: 0
机构:
Robert Koch Inst, D-13353 Berlin, GermanyAvir Green Hills Biotechnol, A-1180 Vienna, Austria
Wolff, Thorsten
Romanova, Julia
论文数: 0引用数: 0
h-index: 0
机构:
Avir Green Hills Biotechnol, A-1180 Vienna, AustriaAvir Green Hills Biotechnol, A-1180 Vienna, Austria
Romanova, Julia
Ruthsatz, Tanja
论文数: 0引用数: 0
h-index: 0
机构:
Avir Green Hills Biotechnol, A-1180 Vienna, AustriaAvir Green Hills Biotechnol, A-1180 Vienna, Austria
Ruthsatz, Tanja
Mayerhofer, Ines
论文数: 0引用数: 0
h-index: 0
机构:
Baxter BioSci, A-2304 Orth, AustriaAvir Green Hills Biotechnol, A-1180 Vienna, Austria
Mayerhofer, Ines
Reiter, Manfred
论文数: 0引用数: 0
h-index: 0
机构:
Baxter BioSci, A-2304 Orth, AustriaAvir Green Hills Biotechnol, A-1180 Vienna, Austria
Reiter, Manfred
Nakowitsch, Sabine
论文数: 0引用数: 0
h-index: 0
机构:
Avir Green Hills Biotechnol, A-1180 Vienna, AustriaAvir Green Hills Biotechnol, A-1180 Vienna, Austria
Nakowitsch, Sabine
Humer, Johannes
论文数: 0引用数: 0
h-index: 0
机构:
Avir Green Hills Biotechnol, A-1180 Vienna, AustriaAvir Green Hills Biotechnol, A-1180 Vienna, Austria
Humer, Johannes
Morokutti, Alexander
论文数: 0引用数: 0
h-index: 0
机构:
Avir Green Hills Biotechnol, A-1180 Vienna, AustriaAvir Green Hills Biotechnol, A-1180 Vienna, Austria
Morokutti, Alexander
Muster, Thomas
论文数: 0引用数: 0
h-index: 0
机构:
Avir Green Hills Biotechnol, A-1180 Vienna, Austria
Med Univ Vienna, Dept Dermatol, A-1090 Vienna, AustriaAvir Green Hills Biotechnol, A-1180 Vienna, Austria
Muster, Thomas
Egorov, Andrej
论文数: 0引用数: 0
h-index: 0
机构:
Avir Green Hills Biotechnol, A-1180 Vienna, AustriaAvir Green Hills Biotechnol, A-1180 Vienna, Austria
Egorov, Andrej
Kittel, Christian
论文数: 0引用数: 0
h-index: 0
机构:
Avir Green Hills Biotechnol, A-1180 Vienna, AustriaAvir Green Hills Biotechnol, A-1180 Vienna, Austria